Spinal cord stimulation (SCS) systems are indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, nonsurgical back pain (without prior surgery and not a candidate for back surgery), and diabetic peripheral neuropathy of the lower extremities. Spinal Column Stimulation A spinal cord stimulator (SCS) is a small device, similar to a pacemaker, that uses electrical impulses to relieve chronic pain of the back, arms, and legs. The device masks pain signals before they reach the brain. Spinal cord stimulation (SCS) systems are indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, nonsurgical back pain, and diabetic peripheral neuropathy of the lower extremities. Spinal Column Stimulation (SCS) Systems is designed to deliver low-intensity electrical impulses to nerve structures. The system is intended to be used with leads and associated extensions that are compatible with the system. SCS systems have a small implanted pulse generator, called a stimulator, and thin wires called leads. These are implanted into your body. The stimulator delivers tiny pulses of mild electric current through the leads to specific nerves on the spinal cord. These impulses mask pain signals traveling to the brain. There are a few types of SCS implants, but each is comprised of three main parts: A battery-powered pulse generator which creates the electrical charge. A lead wire with several electrodes which deliver an electrical charge to the spinal cord. A hand-held remote to power the device on and off and to adjust the settings.
The global market for Spinal Column Stimulation (SCS) Systems was estimated to be worth US$ 2100 million in 2023 and is forecast to a readjusted size of US$ 3734 million by 2030 with a CAGR of 8.1% during the forecast period 2024-2030
North American market for Spinal Column Stimulation (SCS) Systems was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Spinal Column Stimulation (SCS) Systems was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Spinal Column Stimulation (SCS) Systems was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Spinal Column Stimulation (SCS) Systems include Abbott, Boston Scientific Corporation, Medtronic, Nevro, Johns Hopkins Medicine, Axonics Modulation Technologies, ReShape Lifesciences Inc, Cyberonics and SceneRay, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Spinal Column Stimulation (SCS) Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Spinal Column Stimulation (SCS) Systems by region & country, by Type, and by Application.
The Spinal Column Stimulation (SCS) Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Column Stimulation (SCS) Systems.
麻豆原创 Segmentation
By Company
Abbott
Boston Scientific Corporation
Medtronic
Nevro
Johns Hopkins Medicine
Axonics Modulation Technologies
ReShape Lifesciences Inc
Cyberonics
SceneRay
RISHNA
Segment by Type:
Rechargeable
Battery-Operated
Segment by Application
Regional Pain Syndromes
Lumbar Spine Failure Syndrome
Neuropathic Pain in Limbs
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Spinal Column Stimulation (SCS) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Spinal Column Stimulation (SCS) Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Spinal Column Stimulation (SCS) Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Spinal Column Stimulation (SCS) Systems Product Introduction
1.2 Global Spinal Column Stimulation (SCS) Systems 麻豆原创 Size Forecast
1.2.1 Global Spinal Column Stimulation (SCS) Systems Sales Value (2019-2030)
1.2.2 Global Spinal Column Stimulation (SCS) Systems Sales Volume (2019-2030)
1.2.3 Global Spinal Column Stimulation (SCS) Systems Sales Price (2019-2030)
1.3 Spinal Column Stimulation (SCS) Systems 麻豆原创 Trends & Drivers
1.3.1 Spinal Column Stimulation (SCS) Systems Industry Trends
1.3.2 Spinal Column Stimulation (SCS) Systems 麻豆原创 Drivers & Opportunity
1.3.3 Spinal Column Stimulation (SCS) Systems 麻豆原创 Challenges
1.3.4 Spinal Column Stimulation (SCS) Systems 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Spinal Column Stimulation (SCS) Systems Players Revenue Ranking (2023)
2.2 Global Spinal Column Stimulation (SCS) Systems Revenue by Company (2019-2024)
2.3 Global Spinal Column Stimulation (SCS) Systems Players Sales Volume Ranking (2023)
2.4 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Company Players (2019-2024)
2.5 Global Spinal Column Stimulation (SCS) Systems Average Price by Company (2019-2024)
2.6 Key Manufacturers Spinal Column Stimulation (SCS) Systems Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Spinal Column Stimulation (SCS) Systems Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Spinal Column Stimulation (SCS) Systems
2.9 Spinal Column Stimulation (SCS) Systems 麻豆原创 Competitive Analysis
2.9.1 Spinal Column Stimulation (SCS) Systems 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Spinal Column Stimulation (SCS) Systems Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Column Stimulation (SCS) Systems as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rechargeable
3.1.2 Battery-Operated
3.2 Global Spinal Column Stimulation (SCS) Systems Sales Value by Type
3.2.1 Global Spinal Column Stimulation (SCS) Systems Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Spinal Column Stimulation (SCS) Systems Sales Value, by Type (2019-2030)
3.2.3 Global Spinal Column Stimulation (SCS) Systems Sales Value, by Type (%) (2019-2030)
3.3 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Type
3.3.1 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Spinal Column Stimulation (SCS) Systems Sales Volume, by Type (2019-2030)
3.3.3 Global Spinal Column Stimulation (SCS) Systems Sales Volume, by Type (%) (2019-2030)
3.4 Global Spinal Column Stimulation (SCS) Systems Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Regional Pain Syndromes
4.1.2 Lumbar Spine Failure Syndrome
4.1.3 Neuropathic Pain in Limbs
4.1.4 Other
4.2 Global Spinal Column Stimulation (SCS) Systems Sales Value by Application
4.2.1 Global Spinal Column Stimulation (SCS) Systems Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Spinal Column Stimulation (SCS) Systems Sales Value, by Application (2019-2030)
4.2.3 Global Spinal Column Stimulation (SCS) Systems Sales Value, by Application (%) (2019-2030)
4.3 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Application
4.3.1 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Spinal Column Stimulation (SCS) Systems Sales Volume, by Application (2019-2030)
4.3.3 Global Spinal Column Stimulation (SCS) Systems Sales Volume, by Application (%) (2019-2030)
4.4 Global Spinal Column Stimulation (SCS) Systems Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Spinal Column Stimulation (SCS) Systems Sales Value by Region
5.1.1 Global Spinal Column Stimulation (SCS) Systems Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Spinal Column Stimulation (SCS) Systems Sales Value by Region (2019-2024)
5.1.3 Global Spinal Column Stimulation (SCS) Systems Sales Value by Region (2025-2030)
5.1.4 Global Spinal Column Stimulation (SCS) Systems Sales Value by Region (%), (2019-2030)
5.2 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Region
5.2.1 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Region (2019-2024)
5.2.3 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Region (2025-2030)
5.2.4 Global Spinal Column Stimulation (SCS) Systems Sales Volume by Region (%), (2019-2030)
5.3 Global Spinal Column Stimulation (SCS) Systems Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
5.4.2 North America Spinal Column Stimulation (SCS) Systems Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
5.5.2 Europe Spinal Column Stimulation (SCS) Systems Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
5.6.2 Asia Pacific Spinal Column Stimulation (SCS) Systems Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
5.7.2 South America Spinal Column Stimulation (SCS) Systems Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
5.8.2 Middle East & Africa Spinal Column Stimulation (SCS) Systems Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Spinal Column Stimulation (SCS) Systems Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Spinal Column Stimulation (SCS) Systems Sales Value
6.2.1 Key Countries/Regions Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.2.2 Key Countries/Regions Spinal Column Stimulation (SCS) Systems Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.3.2 United States Spinal Column Stimulation (SCS) Systems Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Spinal Column Stimulation (SCS) Systems Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.4.2 Europe Spinal Column Stimulation (SCS) Systems Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Spinal Column Stimulation (SCS) Systems Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.5.2 China Spinal Column Stimulation (SCS) Systems Sales Value by Type (%), 2023 VS 2030
6.5.3 China Spinal Column Stimulation (SCS) Systems Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.6.2 Japan Spinal Column Stimulation (SCS) Systems Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Spinal Column Stimulation (SCS) Systems Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.7.2 South Korea Spinal Column Stimulation (SCS) Systems Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Spinal Column Stimulation (SCS) Systems Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.8.2 Southeast Asia Spinal Column Stimulation (SCS) Systems Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Spinal Column Stimulation (SCS) Systems Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Spinal Column Stimulation (SCS) Systems Sales Value, 2019-2030
6.9.2 India Spinal Column Stimulation (SCS) Systems Sales Value by Type (%), 2023 VS 2030
6.9.3 India Spinal Column Stimulation (SCS) Systems Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Spinal Column Stimulation (SCS) Systems Product Offerings
7.1.5 Abbott Recent Development
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Company Information
7.2.2 Boston Scientific Corporation Introduction and Business Overview
7.2.3 Boston Scientific Corporation Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boston Scientific Corporation Spinal Column Stimulation (SCS) Systems Product Offerings
7.2.5 Boston Scientific Corporation Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medtronic Spinal Column Stimulation (SCS) Systems Product Offerings
7.3.5 Medtronic Recent Development
7.4 Nevro
7.4.1 Nevro Company Information
7.4.2 Nevro Introduction and Business Overview
7.4.3 Nevro Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Nevro Spinal Column Stimulation (SCS) Systems Product Offerings
7.4.5 Nevro Recent Development
7.5 Johns Hopkins Medicine
7.5.1 Johns Hopkins Medicine Company Information
7.5.2 Johns Hopkins Medicine Introduction and Business Overview
7.5.3 Johns Hopkins Medicine Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Johns Hopkins Medicine Spinal Column Stimulation (SCS) Systems Product Offerings
7.5.5 Johns Hopkins Medicine Recent Development
7.6 Axonics Modulation Technologies
7.6.1 Axonics Modulation Technologies Company Information
7.6.2 Axonics Modulation Technologies Introduction and Business Overview
7.6.3 Axonics Modulation Technologies Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Axonics Modulation Technologies Spinal Column Stimulation (SCS) Systems Product Offerings
7.6.5 Axonics Modulation Technologies Recent Development
7.7 ReShape Lifesciences Inc
7.7.1 ReShape Lifesciences Inc Company Information
7.7.2 ReShape Lifesciences Inc Introduction and Business Overview
7.7.3 ReShape Lifesciences Inc Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.7.4 ReShape Lifesciences Inc Spinal Column Stimulation (SCS) Systems Product Offerings
7.7.5 ReShape Lifesciences Inc Recent Development
7.8 Cyberonics
7.8.1 Cyberonics Company Information
7.8.2 Cyberonics Introduction and Business Overview
7.8.3 Cyberonics Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cyberonics Spinal Column Stimulation (SCS) Systems Product Offerings
7.8.5 Cyberonics Recent Development
7.9 SceneRay
7.9.1 SceneRay Company Information
7.9.2 SceneRay Introduction and Business Overview
7.9.3 SceneRay Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.9.4 SceneRay Spinal Column Stimulation (SCS) Systems Product Offerings
7.9.5 SceneRay Recent Development
7.10 RISHNA
7.10.1 RISHNA Company Information
7.10.2 RISHNA Introduction and Business Overview
7.10.3 RISHNA Spinal Column Stimulation (SCS) Systems Sales, Revenue and Gross Margin (2019-2024)
7.10.4 RISHNA Spinal Column Stimulation (SCS) Systems Product Offerings
7.10.5 RISHNA Recent Development
8 Industry Chain Analysis
8.1 Spinal Column Stimulation (SCS) Systems Industrial Chain
8.2 Spinal Column Stimulation (SCS) Systems Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Spinal Column Stimulation (SCS) Systems Sales Model
8.5.2 Sales Channel
8.5.3 Spinal Column Stimulation (SCS) Systems Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Abbott
Boston Scientific Corporation
Medtronic
Nevro
Johns Hopkins Medicine
Axonics Modulation Technologies
ReShape Lifesciences Inc
Cyberonics
SceneRay
RISHNA
听
听
*If Applicable.
